According to information published by GlobalData, 1200 clinical trials were disrupted by COVID-19. In this webinar, Ian Hoban, Business Development Director (Clinical Trial Solutions), talks about the risks and the actions that can be implemented to avoid the “COVID Timebomb.”
Simon Estcourt, Managing Director, and Warren Crawford, Corporate Development Director, also make short presentations to introduce Aposave and the Clinical Trials Solutions Service.
